It remains uncertain how the DNA sequence of mammalian genes influences the transcriptional response to extracellular signals. Here, we show that the number of CREB-binding sites (CREs) affects whether the related histone acetyltransferases (HATs) CREB-binding protein (CBP) and p300 are required for endogenous gene transcription. Fibroblasts with both CBP and p300 knocked-out had strongly attenuated histone H4 acetylation at CREBtarget genes in response to cyclic-AMP, yet transcription was not uniformly inhibited. Interestingly, dependence on CBP/p300 was often different between reporter plasmids and endogenous genes. Transcription in the absence of CBP/p300 correlated with endogenous genes having more CREs, more bound CREB, and more CRTC2 (a non-HAT coactivator of CREB). Indeed, CRTC2 rescued cAMP-inducible expression for certain genes in CBP/p300 null cells and contributed to the CBP/p300-independent expression of other targets. Thus, endogenous genes with a greater local concentration and diversity of coactivators tend to have more resilient-inducible expression. This model suggests how gene expression patterns could be tuned by altering coactivator availability rather than by changing signal input or transcription factor levels.
Introduction
One implicit view of gene regulation is that a model coactivation mechanism for a particular DNA-binding transcription factor is essential for the expression of all its target genes. Another commonly held notion is that histone hyperacetylation is required for gene expression, as it strongly correlates with active transcription. These ideas underlie reductionist approaches to understand transcription factor function, as well as global methods to map the occurrence of transcriptional regulators and histone modifications in the genome. Complicating these notions is evidence based on synthetic plasmid reporter genes and overexpressed coactivators (Koutroubas et al, 2008) , as well as endogenous factors and genes (Kasper et al, 2005; Kasper and Brindle, 2006; Xu et al, 2007; Ramirez-Carrozzi et al, 2009) , that a particular signalresponsive coactivation mechanism is not required at all target genes in mammals.
The critical characteristics of individual endogenous genes that determine their coactivator requirements have been unclear for cAMP and hypoxia signalling (Kasper et al, 2005; Kasper and Brindle, 2006; Xu et al, 2007) . But recent insight has been gained for Toll-like receptor (TLR)-responsive genes in macrophages, a pathway that does not involve cAMP (Hargreaves et al, 2009; Ramirez-Carrozzi et al, 2009 ). In one model, primary TLR-responsive genes are maintained in a permissive state by constitutive transcription factors such as SP1 that binds GC-rich motifs, and regulated by inducible factors that recruit coactivators that promote histone H4 acetylation (Hargreaves et al, 2009) . In a related model, TLR-responsive promoters that are rich in CpG dinucleotides assemble unstable nucleosomes, which reduces their dependence on SWI/SNF nucleosome remodelling coactivators (Ramirez-Carrozzi et al, 2009 ). Other DNA characteristics besides CpG and GC richness must exist, however, as these models are insufficient to fully explain the requirements that individual genes have for different coactivators (RamirezCarrozzi et al, 2009) .
The coactivators CREB-binding protein (CBP) and p300 comprise the unique KAT3 family of histone acetyltransferases (HATs) and their acetyltransferase domains share little sequence similarity with other HATs (Marmorstein, 2001) , which probably contributes to why CBP and p300 are essential for normal development (Yao et al, 1998; Goodman and Smolik, 2000; Kung et al, 2000; Tanaka et al, 2000; Vo and Goodman, 2001) . RNAi knockdown of dCBP in Drosophila Kc cells (Smolik and Jones, 2007) , and CBP and p300 in immortal HeLa cells (Stauffer et al, 2007) , results in death because of chromosome shredding and mitotic catastrophe. Likewise, mouse lymphocytes lacking both CBP and p300 cannot be generated in vivo Xu et al, 2006; Fukuyama et al, 2009) , suggesting that most cells require some CBP or p300. Here, we describe primary mouse embryonic fibroblasts (MEFs) that are made deficient for both CBP and p300 through the use of Cre/LoxP conditional knockout alleles (Kang-Decker et al, 2004; , providing a first opportunity to assess transcription and histone acetylation after stably inactivating a major mammalian HAT family.
Results

Stable inactivation of CBP and p300 in MEFs produces a non-uniform effect on cAMP-responsive endogenous gene transcription
To generate MEFs lacking CBP and p300, we treated primary CBP flox/flox ;p300 flox/flox MEFs with adenovirus that expresses Cre recombinase, inactivating both conditional alleles (some MEF isolates were also engineered to carry a recombinationdependent GFP marker gene; Figure 1A ) and FACS purified GFP þ dKO MEFs. Antibodies to CBP and p300 protein were raised against both N-and C-terminal peptides. A non-specific band detected by the p300 antiserum was used as a loading control. Extracts were made 4 days post-Ad-Cre infection, immediately after FACS purification. (C) Indirect immunofluorescence in dKO MEFs showing loss of CBP/p300 proteins. MEFs were stained with a cocktail of antibodies against the N-and C-termini of CBP and p300. Closed yellow arrow marks example of deleted dKO cells. Open white arrows mark examples of non-deleted cells for internal controls. Closed white arrows mark cells null for only CBP or p300 showing partial loss of signal. DAPI stained nuclei. (D) CBP and p300 protein turnover in MEFs. Indirect immunofluorescence of CBP and p300 using antibodies against the C-termini of CBP and p300 in dKO MEFs 1-4 days after Ad-Cre infection. Wild-type cells treated with Ad-Cre are provided for IF signal comparison. DAPI stained nuclei. (E) Growth curve of WT and dKO MEFs. Percent of GFP þ cells expressing Cre recombinase after Ad-Cre infection was assessed by flow cytometry and applied to cell count. Two independent MEF isolates of each genotype used. (F) dKO MEFs in culture 16 days after floxed gene deletion. Closed arrows indicate GFP þ cells that are null for CBP and p300.
Although proliferation was dramatically reduced, dKO MEFs remained viable in culture for 42 weeks, allowing them to be used for transcriptional studies ( Figure 1E and F). CBP and p300 are prototypical signal-responsive coactivators recruited to DNA-bound CREB after its phosphorylation in response to cAMP, an event that is considered essential for the transcription of CREB-target genes ( Figure 2A ) (Johannessen et al, 2004; Carlezon et al, 2005; Hong et al, 2005; Hyman et al, 2006; Cohen and Greenberg, 2008; Flavell and Greenberg, 2008; Sands and Palmer, 2008 microarray analysis of 193 genes (347 probe sets) that were induced at least 2.5-fold in WT MEFs by 90 min treatment with cAMP agonists 10 mM forskolin plus 100 mM IBMX (FI) ( Figure 2B ). In contrast to the conventional model, however, individual cAMP-inducible genes showed a wide range of dependence on CBP/p300, including some that were unaffected, or even expressed better, in the absence of CBP/p300. As a control, microarray analysis showed that non-cAMPresponsive genes were generally less affected by loss of CBP and p300 ( Figure 2C ) and that many housekeeping genes, including Pgk1 (which we used for normalization), were expressed normally in dKO MEFs (Supplementary Figure S4) . Assessment of individual cAMP-inducible genes by qRT-PCR verified that the expression of some genes, such as Areg and Rgs2, was reduced in dKO MEFs ( Figure 2D and E), whereas other genes were unaffected (e.g. Crem Icer; Figure 2F ) or displayed higher expression (e.g. Nr4a3; Figure 2G ). Additional qRT-PCR analysis of 35 cAMP-inducible genes confirmed that their dependence on CBP/p300 for expression represented a continuum from very CBP/p300 dependent to those more highly expressed in the absence of CBP/p300 ( Figure 2H ).
cAMP-induced genes that are expressed well in dKO MEFs are dependent on CREB Differences in the requirement of CBP/p300 for gene expression might be explained by reliance on non-CREB transcription factors. We next confirmed that cAMP-responsive genes in MEFs are dependent on CREB by using a retrovirus expressing the dominant-negative A-CREB, which specifically inhibits the DNA-binding activity of all three CREB family members (Ahn et al, 1998) . We found that the cAMP-dependent expression of 34 of the 35 genes listed in Figure 2H was markedly reduced by A-CREB (Bhlhb2 was only moderately affected by A-CREB) ( Figure 3A ). In addition, the increased expression seen in a subset of cAMP-inducible genes in dKO MEFs was also blocked by A-CREB, indicating that this phenomenon is CREB dependent as well.
We next tested whether the CBP/p300-independent genes Nr4a1, Nr4a3, Fosb, and Junb were also independent of the main CBP-p300 interaction surface of CREB. For this, we used another CREB dominant negative (Ser133Ala) that alters a phosphorylation site necessary for interaction with the KIX domain of CBP/p300. CREB S133A attenuates but does not block CBP/p300 recruitment (Xu et al, 2007) . As might be expected, CREB S133A had no effect on target gene expression in dKO MEFs (Supplementary Figure S5) . In contrast, it partially repressed the expression of all but Junb in WT MEFs. This result suggests that several of the tested CREB targets are at least partly CBP/p300 dependent in WT MEFs, but are activated through another mechanism in the absence of CBP/p300 (see Discussion). Alternatively, the CREB phospho-Ser133 interaction with KIX may potentiate transcription, whereas other domains of CBP/p300 act to repress it.
To test the latter possibility that in certain contexts either CBP or p300 acts as a repressor, we looked at gene expression in MEFs null for either CBP or p300. Here, we found modest inhibition, or little change, in the expression of Fos, Fosb, Junb, Nr4a1, Nr4a2, and Nr4a3, genes that were more highly expressed in dKO MEFs (Supplementary Figure S6) . This indicates that neither CBP nor p300 individually behave as a strong repressor of these genes.
To help rule out non-transcriptional effects, primary transcript analysis of a subset of genes representing all CBP/p300 dependence categories was performed and showed that the levels of unspliced transcripts mirrored that seen for spliced mRNA ( Supplementary Figures S7A-E ; compare with Figure  2D -G). Thus, the great majority of cAMP-responsive genes in WT and dKO MEFs are transcriptionally regulated by CREB.
cAMP-responsive genes that recruit CBP/p300 efficiently in WT MEFs tend to be less transcriptionally inhibited in dKO MEFs
The non-uniform transcriptional response to cAMP in dKO MEFs suggested that CBP/p300-independent genes might not recruit CBP/p300 in WT MEFs, which would be inconsistent with the standard model for CREB function. Quantitative PCR chromatin immunoprecipitation (ChIP) assays showed that CBP and p300 were recruited to CREB-target genes in response to cAMP in WT MEFs, although to varying degrees, depending on the gene ( Figure 3B Figure 2F and G). Paradoxically, this result implies that the amount of CBP/p300 recruited to a gene in response to cAMP cannot definitively predict its transcriptional requirement for these coactivators.
Histone acetylation in response to cAMP is highly dependent on CBP/p300
Acetylation of histone N-terminal tail lysines correlates strongly with active transcription (Li et al, 2007; Rando and Chang, 2009) , and acetylated H4 in particular is important for signal-responsive gene expression by binding bromodomain protein-4, which recruits transcriptional elongation factors (Hargreaves et al, 2009) . We therefore expected that non-CBP/p300 HATs would acetylate H4 in response to cAMP at genes that were well expressed in the absence of CBP/p300. We performed ChIP assays of 13 cAMP-inducible genes that span the continuum of CBP/p300-transcriptional dependence, using WT and dKO MEFs and antibodies against acetylated H4 lysines K5, K8, K12, and K16. We found that inducible acetylation of these residues was measurable at the CRE-containing regions of most but not all promoters and was CBP/p300 dependent ( Figure 3C -F). Querying the region located B500 bases downstream of the transcriptional start site (TSS) of cAMP-inducible genes gave similar results (data not shown). Surprisingly, the genes with the highest levels of cAMP-inducible H4 acetylation were among those that least required CBP/p300 for their expression ( Figure 3C -F). In contrast, most CBP/p300-dependent genes showed little or no cAMP-responsive acetylation of the H4 lysines tested ( Figure 3C-F) .
The inducible acetylation of histone H3 K9, K14, and K18 was also examined by ChIP at cAMP-responsive promoters and was found to correlate with H4 acetylation in WT cells (compare Figure Figure S8A) . In contrast, inducible acetylation of H3 K18 was extremely dependent on CBP and p300 at all promoters tested by ChIP; the same was true for basal K18 acetylation in bulk H3 (Horwitz et al, 2008) (Supplementary Figures S8B and C) . As with CBP/p300 recruitment, these results show that there is generally an inverse correlation between the amount of cAMP-inducible H3 and H4 acetylation and transcriptional dependence on CBP/p300. These findings also indicate that it is unlikely that there is a redundant HAT that inducibly acetylates H4 and H3K18 in the absence of CBP/p300. This suggests that inducible H4 and H3K18 acetylation is incidental and is not strictly required for the cAMP-responsive transcription of at least some genes.
CBP with HAT domain mutations can rescue certain CREB-target genes
The poor inducible histone acetylation seen at some CBP/ p300-dependent genes suggested that they require a coactivator function of CBP/p300 other than HAT activity for their cAMP-dependent expression. To test this, we used retroviruses to express either WT or HAT mutant HA epitopetagged mouse CBP (CBP-HA) in dKO MEFs and looked for rescue of CBP/p300-dependent gene expression. We used two HAT mutants, W1503A/Y1504S (WY/AS) that strongly affect binding to acetyl-coenzyme A and catalysis, and F1390A/ P1391A/Y1392A (FPY/AAA) that inhibits histone acetylation, but not autoacetylation (Bordoli et al, 2001; Liu et al, 2008a; Bowers et al, 2010) . These CBP-HA proteins were expressed at levels comparable with endogenous CBP (Supplementary Figure S9) . WT CBP-HA rescued cAMP-responsive transcription in dKO MEFs, and both HAT mutants were able to partially rescue expression of Areg ( Figure 3G ). The FPY/ AAA, but not WY/AS, mutant was able to rescue Rgs2 expression ( Figure 3H ), suggesting that this gene may have particular acetylation requirements for proteins besides histones. Neither CBP HAT mutant could rescue the CBP/p300-dependent genes Kcne4 and Nppc, however ( Figure 3I and J). These results suggest that a subset of CREB-target genes use non-HAT coactivator functions of CBP/p300 for their cAMPinducible expression, possibly explaining why inducible H4 acetylation correlates imperfectly with transcription.
The quantity of CREB-binding sites (CREs), bound CREB, and recruited coactivators at endogenous genes correlates with increased transcriptional resilience in response to cAMP in dKO cells
The limited correlation between the requirement of CBP/ p300 for transcription and the level of CBP/p300 recruitment (and CBP/p300-dependent histone acetylation) led us to search for additional mechanisms to explain CBP/p300 dependence for cAMP-inducible genes. We noticed that several CBP/p300-independent genes had more than one CRE close to the TSS (not shown), implying that multiple CREs confer resistance to the loss of CBP/p300. We tested this hypothesis using synthetic luciferase reporters driven by two, four, or six copies of a canonical CRE, as well as reporters driven by À500 to þ 60 bp promoter fragments from four different CREB-target genes. We found that there was no correlation between the number of CREs and CBP/p300 dependence; however, the activities of the promoter fragments poorly matched that of the cognate endogenous genes (Supplementary Figure S10) . This suggested that the non-uniform dependence of CREB-target promoters on CBP/p300 is dictated by DNA sequences that are missing in the plasmids or requires an endogenous gene context.
We, therefore, focused on endogenous loci by determining the number of CREs (TGACG) in the 2 kb region centered on the TSS of 172 genes having clearly annotated promoters that are induced at least 2.5-fold by cAMP in WT MEFs based on Affymetrix microarrays. We found that the number of CREs correlated significantly with CBP/p300 independence as measured by the log 2 ratio of dKO to WT cAMP-induced expression signals, in which negative numbers denote CBP/ p300 dependence ( Figure 4A ; Pearson's correlation, P ¼ 8.8 Â 10
À10
, N ¼ 172, r ¼ 0.44, 95% CI of r ¼ 0.32 to 0.56, where r ¼ 1 denotes a perfect positive correlation, r ¼ 0 is no correlation and r ¼ À1 is a perfect inverse correlation). The number of CpG dinucleotides (corrected for TGACG CREs; the bold, underlined CG in the TGACG sequence is to indicate that every canonical CRE contains a CG dinucleotide, hence the need to correct for the number of CREs) in the region 200 bp upstream of the TSS (À200 to À1) was also determined for comparison with a described CpG-dependent mechanism for TLR-responsive transcription (Ramirez-Carrozzi et al, 2009), but it correlated less well with CBP/p300 independence (Supplementary Figure S11A ; P ¼ 0.0015, r ¼ 0.24, 95% CI ¼ 0.09 to 0.38, N ¼ 172). This suggests that CpG-associated mechanisms contribute less to CREB-target gene regulation than those involving CREs. Indeed, the total variation in gene expression explained by CRE motifs was about 20%, whereas for CG motifs it was only 2%. In addition, as the effect of CG motifs becomes almost negligible after adjusting for the presence of CREs, it suggests that there is no significant synergistic effect between the two motifs (regression analysis for multiple variables). Another described TLR-responsive mechanism involving GC-rich SP1 sites (Hargreaves et al, 2009) did not appear to be important for cAMP-responsive genes as there was neither a significant correlation between the number of SP1 sites (À1 kb to þ 1 kb from TSS) and CBP/p300 independence (Supplementary Figure S11B ; P ¼ 0.14, N ¼ 172), nor did GC nucleotide content in the À200 to À1 region correlate significantly (Supplementary Figure S11C ; P ¼ 0.054, N ¼ 172). Together, these findings indicate that the cAMP-induced expression of genes with more CREs tends to be more resistant to the loss of CBP/p300, whereas CpG-associated mechanisms may contribute, but less so, to CBP/p300 independence.
'CREB-rich' promoters are 'coactivator-rich' and are apt to be more resistant to the loss of CBP/p300
The highly significant (albeit broad) correlation between the number of CREs and CBP/p300 independence could reflect differences in the way CRE-containing promoters recruit transcriptional co-factors or in how such co-factors function.
We tested the first of these hypotheses that promoters with more CREs would recruit CREB (and thereby coactivators) more efficiently than promoters with fewer CREs. We performed ChIP assays using antibodies against CREB, CBP/ p300, and the non-HAT protein CRTC2 (TORC2, a cAMPresponsive CREB coactivator unrelated to CBP/p300; These results indicate that CRE-rich promoters have more bound CREB, which recruits CBP/p300 and CRTC2 more efficiently. Moreover, the strong correlations suggest that both CBP/p300 and CRTC2 are recruited by CREB, rather than by some other transcription factor. The near perfect correlation between the CBP/p300 and CRTC2 recruitment levels ( Figure 4E ; Pearson's r ¼ 0.95, Po0.0001) led us to model the existence of 'coactivatorrich' and 'coactivator-poor' promoters ( Figure 4F ). In this model, a given promoter recruits a transcription factor poorly or strongly based on the quality and number of binding sites; coactivators of different types are recruited correspondingly (i.e. more transcription factor corresponds to more coactivator recruitment). Our model predicts that promoters with low levels of CREB and coactivator recruitment will be more dependent on each individual type of coactivator (and their particular biochemical function that leads to transactivation, e.g. histone acetylation) for gene expression. On the other hand, promoters that recruit coactivators strongly will benefit from buffering between coactivator transactivating mechanisms and be less dependent on any particular coactivator class. Indeed, comparison of the ChIP signals for CREB, CBP/p300, and CRTC2 with the CBP/p300 dependence of expression for these 24 genes all gave significant correlations (Figure 4G -I; Pearson's correlation, N ¼ 24, CREB ChIP r ¼ 0.52, P ¼ 0.0087; CBP/p300 ChIP r ¼ 0.54, P ¼ 0.0065; CTRC2 ChIP r ¼ 0.48, P ¼ 0.0171). This model helps explain the paradox of why the genes that recruit the most CBP and p300 in response to cAMP tend to need them the least for their inducible expression; in these cases, abundant CBP/ p300 recruitment is a proxy for abundant coactivator recruitment in general (in this instance, CRTC2 and perhaps others).
CRTC2 overexpression increases its recruitment to CREB targets and rescues the expression of certain genes in the absence of CBP/p300 Implicit in our coactivator recruitment model are two hypotheses: (1) different classes of coactivators can provide redundancy for each other in certain promoter contexts and (2) rescue of gene expression in dKO cells could occur if the local concentration of a different coactivator could be increased. To test these hypotheses, we overexpressed CRTC2 in WT and dKO MEFs and examined CBP/p300-dependent genes for expression and CRTC2 recruitment. ChIP showed that CRTC2 overexpression in both WT and dKO MEFs increased the recruitment of CRTC2 to CBP/p300-dependent promoters in a cAMP-dependent manner (Figure 5A -D; N ¼ 2). Interestingly, increased CRTC2 recruitment occurred at CBP/p300-dependent genes that were rescued by CRTC2 (Areg, Has1, Figure 5A , B, E and F; N ¼ 2-3), as well as at genes that were not rescued by CRTC2 overexpression (1810011O10Rik, Dio2; Figure 5C , D, G and H; N ¼ 2-3). Another six CBP/p300-dependent genes also showed partial to complete rescue by CRTC2 (Supplementary Figure S12) , although most genes examined did not (data not shown). This data indicates that distinct types of coactivators (e.g. HATs versus non-HATs) can provide redundancy in certain gene contexts if there is a sufficiently high local coactivator concentration. Consistent with our model (Figure 4F ), coactivator recruitment could be driven both by a greater local concentration of DNA-bound transcription factor (i.e. CREB), and by increasing the total amount of coactivator in the cell.
This result suggested that CBP/300-independent gene expression might in part be due to increased expression of endogenous Crtc1 and Crtc2 in dKO MEFs. Indeed, qRT-PCR showed about a three-fold increase of Crtc1 and Crtc2 mRNA in dKO MEFs compared with WT (Supplementary Figure  S13) . CRTC2 protein level was similarly increased in dKO MEFs ( Figure 6J ). Endogenous CRTC2 recruitment as measured by ChIP also tended to increase somewhat at CBP/ p300-independent genes (e.g. Fosb, Nr4a3) in dKO MEFs, an effect that was not observed for genes such as Areg and 1810011O10Rik that are highly dependent on CBP/p300 ( Figure 5; Supplementary Figure S14) . These results agree with the notion that promoters for CBP/p300-independent genes such as Nr4a3 compete more effectively for limiting amounts of coactivators, which helps buffer their expression.
CRTC knockdown reduces the CBP/p300-independent expression of some CREB-target genes in dKO MEFs
The data and model ( Figure 4F ) predicts that the CBP/p300-independent expression of some cAMP-inducible genes in dKO MEFs is due to the presence of another CREB-recruited coactivator such as CRTC at these promoters. To test this, we knocked down CRTC1 and CRTC2 by transient transfection with Crtc1 and Crtc2 siRNAs and observed the effect on the expression of eight CBP/p300-independent genes ( Figure  6A-H) . Knockdown of CRTC1 and CRTC2 protein and/or mRNA was verified (Figures 6J-L) and was found to reduce the average expression of the CBP/p300-independent genes tested in WT MEFs to 87% of control siRNA-treated cells (95% CI ¼ 98 to 75%, N ¼ 8 genes), whereas in dKO MEFs, it was reduced to 53% (95% CI ¼ 62 to 45%) ( Figure 6I ; Po0.0001). These results were confirmed using a retrovirus expressing an shRNA targeting a different part of the Crtc2 mRNA (Supplementary Figure S15) . The Crtc2 shRNA reduced CREB-target gene expression in dKO MEFs to 58% of the control shRNA (95% CI ¼ 71 to 45%, N ¼ 8 genes), whereas the Crtc2 shRNA had little effect in WT MEFs, as gene expression was 97% of that seen with the control shRNA (95% CI ¼ 107 to 88%, N ¼ 8) (Supplementary Figure S15I; Po0.0001). These findings agree with our model, which predicts that the presence of CBP/p300 in WT cells should buffer certain genes from lower amounts of CRTC. Together, this suggests that CRTC coactivators are at least partly responsible for the CBP/p300-independent CREB-target gene expression seen in dKO MEFs.
Discussion
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Relative expression normalized to Pgk1 Relative expression normalized to Pgk1 stably deficient for one of the major mammalian HAT families (CBP and p300 having at least 400 described interacting protein partners; Bedford et al, 2010) . It was unexpected that many CBP/p300-independent genes would robustly recruit CBP/p300 in WT MEFs, but not retain inducible histone acetylation through redundant HATs in dKO MEFs. This suggests that at least some CBP/p300-dependent histone acetylation marks are bystander events that are not critical for transcription.
In a previous study using MEFs bearing point mutations in the KIX domain of CBP and p300 that disrupt the CREB interaction surface (Xu et al, 2007) , we attributed the nonuniform dependence on the KIX domain for cAMP-inducible gene expression to the residual recruitment of mutant CBP/ p300 through CRTC. We were, therefore, surprised in this study to find that not all CREB-target genes were profoundly inhibited by the absence of CBP/p300. In some but not all cases, there is an interesting lack of concordance in the expression of CREB targets in KIX mutant MEFs compared with dKO MEFs. For example, Nr4a3, which is partially sensitive to the KIX and CREB Ser133Ala mutations (Xu et al, 2007) , is actually expressed better in dKO MEFs than in WT cells. The reason for this distinction between different types of CBP/p300 mutant cells is not entirely clear, but the simplest hypothesis invokes a compensatory mechanism that is more active in dKO cells. A priori, a non-CBP/p300 HAT would seem to be a probable candidate, but our data suggests that this is not the case, as acetylation of certain histone residues was not compensated in the dKO MEFs. Instead, non-HAT coactivators may be involved, and evidence presented here and in our previous study of KIX mutant MEFs (Xu et al, 2007) implicates CRTC, at least in part. For example, Nr4a3 expression in KIX mutant MEFs could be rescued by CRTC2 overexpression (Xu et al, 2007) and the increased expression of Nr4a3 in dKO MEFs was inhibited by CRTC knockdown. Consistent with the idea that endogenous CRTC upregulation is providing some compensation in dKO MEFs, the expression of Crtc1 and Crtc2 was increased, as was CRTC2 recruitment to 'coactivator-rich' genes such as Nr4a3. CRTC2 recruitment did not increase at genes such as Areg in dKO MEFs unless CTRC2 was highly overexpressed, which agrees with the 'coactivator-poor' and 'coactivator-rich' model.
The DNA sequences or other gene characteristics (e.g. location in the nucleus) that determine the extent to which a CREB target requires CBP/p300 are not entirely apparent, but our data indicates that the number of CREs, and to a lesser degree CpG motifs, appears to contribute. The amount of CREB bound at a promoter correlated strongly with more efficient recruitment of coactivators, which we propose buffers the mechanisms that can activate a particular gene. For example, CREB has two signal-responsive activation domains (that bind CBP/p300 and CRTC, respectively), and constitutive glutamine-rich domains similar to SP1 that interact with TFIID ( Figure 2A ) (Ferreri et al, 1994) , thus the amount of CREB at a promoter may singly influence coactivator dependence much as SP1 and NF-kB do together at TLR-responsive genes (Hargreaves et al, 2009) . Accordingly, 'CREB-rich, coactivator-rich' promoters tend to be more resistant to the loss of CBP/p300. Whether CRE number influences the number of CREB and coactivator molecules recruited to individual promoter loci, or affects the stochastic probability that a promoter will recruit CREB and coactivators is an interesting question, but one that cannot be distinguished using bulk cell culture methods.
Our results also refine the popular view that the local occurrence of a coactivator or histone modification equates with their functional importance at a locus. Instead, our findings suggest that CBP/p300, and concomitant histone acetylation, tends to be more abundant at loci in which they are least required for gene expression. Broadly, this implies that functional importance correlates better with the low to moderate local abundance of a particular coactivator or histone modification. This would have implications for interpreting genome-wide mapping studies (e.g. ChIP-seq). Finally, it is interesting to speculate that the different requirements genes have for coactivators may provide a physiological mechanism for tuning the pattern of signalresponsive gene expression by modulating the availability of coactivators.
Materials and methods
Cell culture, plasmids and antibodies MEFs were generated from E14.5 embryos; experiments were performed in primary MEFs between passages 3 and 6 and growth rates and morphology were comparable for WT and floxed allele cells before recombination. To recombine floxed alleles, mutant and control MEFs were treated with adenovirus expressing Cre recombinase at an MOI of 100. All experiments were performed 4 days after recombination (see Figure 1D ) and deletion efficiency was monitored by PCR. Cre reporter transgenes that express eGFP (Novak et al, 2000) or eYFP (Srinivas et al, 2001) after Cre-mediated recombination were bred into the mice and used for MEFs to allow for FACS purification of dKO cells, although this was found to be unnecessary for most experiments; unsorted MEFs were, therefore, used except where noted. MEFs were serum starved overnight before treatment with cAMP agonists, except for siRNA experiments (note that serum tended to blunt the fold response to cAMP). Typically, multiple independent primary MEF isolates were used for each assay to account for biological variation. The cDNA for HA epitope-tagged mouse CBP was cloned out of the vector pRC/RSVmCBP-HA-RK (from R Goodman) into the MSCV retroviral expression vector and mutations were generated by QuickChange Mutagenesis (Stratagene). The A-CREB construct was cloned into MSCV-IRES-GFP. MSCV-CRTC2-IRES-GFP was generated from a cDNA obtained from the mammalian gene collection. The CREB and CREB-S133A MSCV retroviral constructs were described previously (Xu et al, 2007) . Antibodies against bulk histone H3 (ab1791) and H3K18Ac (ab1191) (Abcam) were used for ChIP and western antibodies against bulk histone H4 (05-858), H3K9,14Ac (06-599), acetyl histone H4 antibody set (17-211; including antibodies against acetylated H4K5, K8, K12, and K16) (Upstate/ Millipore) were used for ChIP. HA-11 monoclonal antibody against the HA epitope (Boehringer Mannheim) and CBP (A-22 and C-20) and p300 (N-20 and C-20) antibodies (Santa Cruz) were used for IF. CBP and p300 antisera used for western and ChIP were generated against peptides from the N-and C-termini of CBP and p300, respectively. CBP/p300 antiserum (2574) used for IF was generated against GST-p300 1-328, but detects both CBP and p300 similarly by immunoprecipitation and IF. CRTC2 antiserum was described previously (Xu et al, 2007) . CREB antiserum (244) used for western was a gift from Marc Montminy. Normal rabbit serum used for ChIP was from Sigma.
Nuclear extracts, histone extraction, western blots, and ChIP assays Nuclear extract preparation and western blots were performed as described (Kasper et al, 2002) except CBP/p300 were transferred with 0.1% SDS for 90 min at 400 mA and histones were transferred overnight at 30 V without SDS. Histones were acid extracted as described in Shechter et al (2007) and run on a 15% SDS-PAGE gel for western blotting. ChIP assays followed a modified Upstate Biotechnology Inc. protocol as described previously (Xu et al, 2007) . ChIP primer sets were checked for linear amplification and qPCR ChIP signals were normalized to chromatin input allowing comparison between different samples and primer sets.
Indirect IF
MEFs were seeded on 12-well microscope slides for at least 12 h, fixed in 3% formaldehyde for 10 min at room temperature (RT), washed three times with phosphate-buffered saline (PBS), permeabilized in PBS-0.2% Triton X-100 for 15 min, washed five times in PBS-2% non-fat milk, and incubated overnight with the primary antibodies diluted 1:1000 in PBS-2% non-fat milk. Primary antibodies were visualized with Cy3-conjugated donkey anti-mouse or anti-rabbit antibodies (Jackson ImmunoResearch) diluted 1:500 in PBS-2% non-fat milk. Slides were examined by fluorescence microscopy.
qRT-PCR, microarrays, and primary transcript analysis qRT-PCR and microarray analysis was performed as described previously (Xu et al, 2007) except that gene expression for qRT-PCR was normalized to Pgk1 RNA. Primary transcript analysis was performed as described previously (Kasper et al, 2005) .
CBP-HA, A-CREB, CREB, CREB-S133A, CRTC2, and shRNA retroviral experiments WT and CBP flox/flox ; p300 flox/flox MEFs were infected with retrovirus expressing WT CBP-HA, mutant CBP-HA, GFP (control), A-CREB, CREB, CREB-S133A, CTRC2, or shRNA (shRNA scramble 'complement' sequence: GCACTACCAGAGCTAACTCAGATAGTACT; shRNA CRTC2 complement sequence: GACTGCCGTCTGCACTTAACAGGAC AAGC; shRNA loop sequence; and reverse complement sequence not shown). Percentage of cells infected was determined for CBP-HA by indirect IF and for A-CREB, CREB, CREB-S133A, CRTC2, and shRNA by flow cytometry for GFP (GFP is coexpressed by the retrovirus). The CBP-HA experiments were performed using MEFs in which the infection rate was 450% and comparable between WT and mutant CBP-HA. Cells for A-CREB, CREB, CREB-S133A, CRTC2, and shRNA experiments were sorted for GFP-positive cells if the infection was o90%. After 2 days, cells were treated with adenovirus expressing Cre recombinase at an MOI of 100 and gene expression was tested 4 days later.
siRNA knockdown of CRTC1 and CRTC2 WT and dKO MEFs were transfected as follows: 1 ml of DMEM þ L-glutamine was placed in a 6 cm dish; to it was added 20 ml of 20 mM siRNA (either a non-specific scramble siRNA or a mixture of siRNAs targeting CTRC1 and CTRC2) and 10 ml of RNAiMax Lipfectamine (Invitrogen). Scramble siRNA: CTGTATTGGCGTGACCA GTTT; CRTC1 siRNA: GTCACGGGCCACCTGCACATT; CRTC2 siRNAs: AGACTGCCGTCTGCACTTAACTT, CTGAAACCTTGGGATGCTAAGTT, and CCTGCAGTCCTCCCTAAGCAATT (last two bases are dT). This mixture was incubated at RT for 20 min, then 300 000 MEF cells in 5 ml DMEM þ 10% FBS þ L-glutamine were added. After 72 h in a 371C incubator, the cells were treated with 10 mM forskolin/100 mM IBMX for 90 min and RNA was harvested. For protein extracts, the transfection was scaled up 10-fold in a 15 cm dish.
Statistical analysis and software
Graphs and basic statistical analyses (including Pearson's correlation) were generated using GraphPad Prism. Regression for multiple variables was performed using SAS version 9.1.3 Service Pack 4 (SAS Institute, Inc., Cary, NC). Affymetrix microarray analyses and heat maps were generated using Spotfire. Pearson's correlation P-valueso0.0001 were calculated using Free Statistics Software, Wessa, P (2009), Office for Research Development and Education, version 1.1.23-r4 (URL: http://www.wessa.net/).
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